,13 MITF knockdown led to the downregulation of key molecules, including KIT, CDK2, and BCL2, in both imatinib-sensitive and imatinib-resistant GIST cell lines, evaluated in vivo and in vitro.13 Here, BCL2 is linked to gastrointestinal stromal tumor.